FDA announces new regulatory pathway for personalized rare disease therapiesnews2025-11-12T22:00:19+00:00November 12th, 2025|Endpoints News|
Jury gives Novo Nordisk a win in decade-long hemophilia fraud casenews2025-11-10T20:44:45+00:00November 10th, 2025|Endpoints News|
Delaware judge refuses to block Metsera from ending Pfizer obesity dealnews2025-11-05T21:27:42+00:00November 5th, 2025|Endpoints News|
First Circuit hears arguments over NIH indirect cost cutsnews2025-11-05T20:29:34+00:00November 5th, 2025|Endpoints News|
AbbVie gets early win in Oklahoma 340B fight, but faces setback in Coloradonews2025-11-03T20:18:49+00:00November 3rd, 2025|Endpoints News|
Metsera calls Pfizer threats ‘nonsense’ as rift widens between companiesnews2025-11-03T16:46:46+00:00November 3rd, 2025|Endpoints News|
Pfizer sues to stop Novo’s Metsera takeover attemptnews2025-10-31T20:41:12+00:00October 31st, 2025|Endpoints News|
Hawaii federal judge rules against FDA decision to maintain abortion pill restrictions news2025-10-31T19:27:00+00:00October 31st, 2025|Endpoints News|
Lilly keeps up legal fight against GLP-1 compounders news2025-10-28T19:40:58+00:00October 28th, 2025|Endpoints News|
Organon CEO exits after internal probe over ‘channel stuffing’ to boost salesnews2025-10-27T18:29:50+00:00October 27th, 2025|Endpoints News|
